3rd Quarter - Termination

HOLLAND & KNIGHT LLP for KINDERFARMS, LLC

Firm
Client
Income
$60,000
Expenses
—
Terminated
Sep 30, 2025

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Over-the-counter (OTC) drug and food safety and nutrition issues; OTC monograph User Fee Act (OMUFA) reauthorization; Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); FDA rulemaking on ultraprocessed food.

LobbyistCovered position, as disclosed
JORDAN BROSSI —
JOEL ROBERSON —
MICHAEL WERNER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 4121 (119th), S. 2256 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.